Increasing Lung Transplant Availability Using Normothermic Ex Vivo Lung Perfusion (EVLP) at a Dedicated EVLP Facility

You may be eligible if

• Each patient must meet all of the following criteria to be enrolled in the Study:
• 1. 18 years of age or older.
• 2. Male or female.
• 3. Patient actively awaiting a single or double lung transplant.
• 4. Patient or patient's representative provides informed consent for participation in the study prior to participating in any study-related assessments or procedures.
• 5. Patient matches with and undergoes a transplant with a donor lung.
• Patients who meet any of the following criteria will be excluded from the study:
• 1. Patients listed for same-side lung re-transplantation.
• 2. Patients listed for multiple organ transplantation including lung and any other organ.
• 3. Patients listed for live donor lobar lung transplant.
• 4. Patients positive for human immunodeficiency virus (HIV ) or Burkholderia cenocepacia infection.
• 5. Patient receives a standard of care (non-EVLP ) lung transplant but does not match to an EVLP subject based on the criteria for control matching.
• 6. Transplanted with a lung that was perfused using another EVLP technology.
• 7. Participating in another respiratory or cardiovascular clinical trial.